Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RMC-0331 (RM-023) is an orally available and potent SOS1 inhibitor.RMC-0331 has potential anticancer activity, blocking RAS activation by disrupting RAS-SOS1 interactions.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 372.00 | |
10 mg | In stock | $ 663.00 | |
25 mg | In stock | $ 1,370.00 | |
50 mg | In stock | $ 2,120.00 | |
100 mg | In stock | $ 3,160.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 397.00 |
Description | RMC-0331 (RM-023) is an orally available and potent SOS1 inhibitor.RMC-0331 has potential anticancer activity, blocking RAS activation by disrupting RAS-SOS1 interactions. |
Targets&IC50 | GDP/GTP:71 nM |
In vitro | The IC50 of RMC-0331 is 71 nM, as determined by in vitro GDP/GTP exchange rate measurements[1]. |
In vivo | In the SHP2 mutation model, RMC-0331 exhibits single-agent anti-tumor activity when administered orally at doses ranging from 100 to 250 mg/kg once daily in immunocompetent mice[1]. |
Synonyms | RM-023 |
Molecular Weight | 499.91 |
Formula | C22H25ClF3N5O3 |
CAS No. | 2488788-52-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (200.04 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RMC-0331 2488788-52-7 MAPK Raf RMC 0331 RMC0331 RM-023 inhibitor inhibit